Comparative Study for the Optimal Treatment Method of Lateral Epicondylosis
Tennis Elbow
About this trial
This is an interventional treatment trial for Tennis Elbow focused on measuring Tennis Elbow, lateral epicondylosis, lateral epicondylitis, Platelet-Rich Plasma, Extracorporeal Shockwave Therapy, Prolotherapy, Physiotherapy
Eligibility Criteria
Inclusion Criteria:
- 35 to 80 years of age
- history of elbow pain in the region of the lateral epicondyle for more than 6 months
- more than 3 months of treatment for lateral epicondylosis before enrollment in the study with no subjective improvement
- pain on resisted extension of wrist
- local tenderness to palpation at the lateral epicondyle
- confirmed as lateral epicondylosis on ultrasound imaging
Exclusion Criteria:
- history of steroid or botulinum injection(s) within 6 months before study enrollment
- other elbow pathology including nerve compression, previous elbow fracture, limited elbow range of motion, abnormal simple radiographic findings, history of elbow surgery and inflammatory arthropathies
- upper extremity pain or discomforts from shoulder or wrist or hand
Sites / Locations
- CM Chungmu Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Experimental
Experimental
Physiotherapy
extracorporeal shockwave therapy
Prolotherapy
Platelet-rich plasma
patients were educated to do stretching and eccentric strengthening exercise of wrist extensor muscles
patients were treated with 3 sessions of high-energy shock wave therapy ESWT (Evotron, Switech medical, Kreuzlingen, CH) in 2 weeks interval. Total energy flux density ranged from 0.1 to 0.14 mJ/mm2 (1500 impulses). Shockwave was targeted over lateral epicondyle where maximum tenderness was located.
injection of 20% dextrose (3cc mixed with 0.3cc of lidocaine) to ECRB tendon was done under ultrasound guidance
3 cc of PRP (Harvest SmartPReP 2 APC 30 Process Kit, Harvest Technologies, Plymouth, MA) was injected into ECRB tendon under ultrasound guidance